By Counterforce Health Team in Ozempic / Mounjaro (semaglutide / tirzepatide) —

Getting Ozempic and Mounjaro Covered by UnitedHealthcare in Washington: 2025 Prior Authorization Guide

Answer Box: Quick Path to Coverage

UnitedHealthcare requires prior authorization for Ozempic (semaglutide) and Mounjaro (tirzepatide) in Washington, approved for 12 months when prescribed for type 2 diabetes. Submit through the UHC Provider Portal with A1C ≥6.5% documentation or diabetes medical records. If denied, use Washington's robust appeals process: internal appeals first, then external review through an Independent Review Organization (IRO) via the Office of the Insurance Commissioner. Most appeals succeed with proper documentation—gather your diabetes diagnosis, A1C labs, prior medication history, and provider support letter before starting.

Table of Contents

  1. UnitedHealthcare Policy Overview
  2. Medical Necessity Requirements
  3. Step Therapy and Exceptions
  4. Quantity Limits and Dosing Rules
  5. Required Documentation
  6. Fastest Path to Approval
  7. Appeals Process in Washington
  8. Common Denial Reasons & Solutions
  9. Costs and Savings Options
  10. FAQ

UnitedHealthcare Policy Overview

UnitedHealthcare covers Ozempic and Mounjaro as Tier 2-3 specialty medications for type 2 diabetes management across commercial, Medicare Advantage, and employer plans in Washington. Both medications require prior authorization through OptumRx, UnitedHealthcare's pharmacy benefit manager.

Plan Types and Coverage

  • Commercial/Employer Plans: Standard PA requirements apply
  • Medicare Advantage: Subject to Medicare Part D regulations with UHC-specific criteria
  • Medicaid (Apple Health): Coverage varies; check with Washington Apple Health directly

The medications are not typically covered for weight loss alone under diabetes NDC codes, though this may change as FDA expands indications.

Medical Necessity Requirements

Primary Indication: Type 2 Diabetes

UnitedHealthcare approves these medications when prescribed for type 2 diabetes with evidence of:

  • A1C ≥6.5% (within 90 days), OR
  • Fasting plasma glucose ≥126 mg/dL, OR
  • 2-hour oral glucose tolerance test ≥200 mg/dL, OR
  • Random plasma glucose ≥200 mg/dL with hyperglycemia symptoms

For patients diagnosed more than 2 years ago, medical records confirming ongoing type 2 diabetes treatment are sufficient.

Note: BMI and cardiovascular risk factors are not explicitly required in UnitedHealthcare's current policy for diabetes coverage.

Step Therapy and Exceptions

Standard Step Therapy Requirements

UnitedHealthcare typically requires trial of first-line diabetes medications before approving GLP-1 receptor agonists:

  1. Metformin (unless contraindicated)
  2. Additional oral antidiabetics (sulfonylureas, SGLT2 inhibitors)
  3. Basal insulin (in some cases)

Medical Exception Pathways

You can bypass step therapy if:

  • Previous medications failed to achieve glycemic control
  • Contraindications exist (e.g., kidney disease, allergies)
  • Drug interactions prevent use of alternatives
  • Patient experienced intolerable side effects

Documentation needed: Pharmacy records, provider notes detailing reasons for failure/intolerance, and clinical rationale for bypassing standard therapy.

Quantity Limits and Dosing Rules

Standard Limitations

  • 30-90 day supply maximum per fill
  • Weekly injection dosing must align with FDA labeling
  • Titration schedules as per manufacturer guidelines
  • New members: Up to 30-day temporary supply in first 90 days pending full authorization

Renewal Requirements

Authorization is valid for 12 months and requires renewal with updated:

  • A1C results (within 90 days)
  • Medication adherence records
  • Provider assessment of continued medical necessity

Required Documentation

Essential Documents for Initial Authorization

Document Type Requirement Source
Diabetes Diagnosis ICD-10 codes, A1C ≥6.5%, or glucose criteria Provider records
Prior Medication History Pharmacy records or provider notes Pharmacy/EMR
Clinical Notes Current diabetes management status Provider
Lab Results A1C within 90 days Lab reports

Medical Necessity Letter Checklist

Your provider's letter should include:

  • Patient demographics and insurance information
  • Diabetes diagnosis with supporting lab values
  • Previous treatment history and outcomes
  • Clinical rationale for GLP-1/dual agonist therapy
  • Treatment goals and monitoring plan
  • Guideline citations (ADA Standards of Care, FDA labeling)

Fastest Path to Approval

Step-by-Step Process

  1. Verify Coverage (1-2 days)
    • Log into UHC member portal or call pharmacy benefits number
    • Confirm formulary status and PA requirements
  2. Gather Documentation (3-5 days)
    • Request recent A1C and diabetes records from provider
    • Compile prior medication history from pharmacy
    • Obtain provider support letter
  3. Submit Prior Authorization (Same day)
    • Use UHC Provider Portal (fastest option)
    • Alternative: Call 800-711-4555 or fax to number on denial letter
    • Include all supporting documentation
  4. Track Status (1-15 business days)
    • Monitor through provider portal
    • Standard review: 15 business days
    • Expedited review: 72 hours (with medical urgency documentation)
  5. Follow Up if Needed
    • Request peer-to-peer review if initial denial
    • Prepare for formal appeal process
From our advocates: We've seen the fastest approvals when providers submit complete documentation upfront, including specific A1C values and detailed prior therapy notes. Taking time to gather everything before submitting often prevents the back-and-forth that delays coverage.

Appeals Process in Washington

Washington state provides robust consumer protections for insurance denials through a two-tiered system: internal appeals followed by external review.

Internal Appeals with UnitedHealthcare

First Level - Reconsideration

  • Timeline: Submit within 12 months of denial
  • Method: UHC Provider Portal, phone (800-711-4555), or mail
  • Decision: 10 business days
  • Required: All clinical documentation, provider support

Second Level - Formal Appeal

  • Timeline: After first-level denial
  • Process: Includes peer-to-peer physician review option
  • Decision: 15-30 days
  • Expedited: 72 hours for urgent medical needs

External Review via Washington IRO Process

After exhausting internal appeals, Washington residents can request Independent Review Organization (IRO) review under RCW 48.43.535.

Key Details:

  • Eligibility: Final internal adverse determination for non-grandfathered plans
  • Timeline: File within 4 months of internal denial (72 hours for expedited)
  • Process: Office of the Insurance Commissioner assigns independent IRO
  • Decision: 45 days standard, 18 days expedited
  • Outcome: Binding on UnitedHealthcare if overturned

How to File:

  • Submit Form H-46A to: Office of the Insurance Commissioner, External Review Unit, PO Box 40255, Olympia, WA 98504-0255
  • Fax: (360) 586-3535
  • Online portal: insurance.wa.gov
  • Help line: (800) 562-6900
Tip: Washington's external review process has approximately 70% overturn rate for medical necessity denials. The independent medical experts often side with patients when proper clinical evidence is provided.

Common Denial Reasons & Solutions

Denial Reason Solution Documentation Needed
Missing diabetes diagnosis Submit current A1C ≥6.5% or glucose criteria Lab reports, provider notes
Step therapy not completed Request medical exception Prior medication records, failure/intolerance documentation
Insufficient medical necessity Provide detailed clinical rationale Provider letter, treatment goals, monitoring plan
Using for weight loss Clarify diabetes indication ICD-10 codes, diabetes management records
Quantity limits exceeded Request utilization exception Clinical justification for higher doses/quantities

Scripts for Common Situations

Patient Phone Script for UnitedHealthcare: "I'm calling about a prior authorization denial for [Ozempic/Mounjaro] prescribed for my type 2 diabetes. My reference number is [X]. Can you tell me the specific reason for denial and what documentation is needed for approval? I'd also like to know about the appeals process and any expedited options."

Clinic Staff Script for Peer-to-Peer: "I'm requesting a peer-to-peer review for [patient name] regarding [medication] denial. The patient has type 2 diabetes with A1C of [X]% despite [prior therapies]. I have clinical documentation supporting medical necessity and would like to discuss with your medical director."

Costs and Savings Options

Manufacturer Support Programs

  • Ozempic: Novo Nordisk offers savings card reducing copays to $25/month for eligible commercial patients
  • Mounjaro: Eli Lilly Savings Card provides $25 copay for 1-3 months for qualified patients

Additional Resources

  • Medicare Extra Help: Low-income Medicare beneficiaries may qualify for reduced Part D costs
  • Foundation Grants: Patient advocacy organizations sometimes provide emergency assistance
  • Pharmacy Discount Programs: GoodRx and similar services for uninsured periods

Bridge Options During Appeals

  • Emergency supplies: 7-30 day temporary fills while appeals are pending
  • Manufacturer assistance: Contact drug companies directly for patient assistance programs
  • Alternative medications: Discuss with provider about covered alternatives during appeal process

Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical notes to create targeted, evidence-backed rebuttals. Their platform helps patients, clinicians, and specialty pharmacies navigate the complex prior authorization landscape with payer-specific workflows and automated appeal generation.

FAQ

How long does UnitedHealthcare prior authorization take in Washington? Standard review takes 15 business days. Expedited review (for urgent medical needs) takes 72 hours. Automated approvals through OptumRx PreCheck can process in under 30 seconds for eligible cases.

What if Ozempic or Mounjaro is non-formulary on my plan? You can request a formulary exception with clinical justification. If denied, appeal through internal and external review processes. The IRO can override plan restrictions if medically necessary.

Can I request expedited appeals in Washington? Yes, for urgent medical situations where standard timelines could jeopardize your health. Submit expedited requests within 72 hours with documentation of medical urgency.

Does step therapy apply if I tried medications outside Washington? Yes, prior medication history from other states counts toward step therapy requirements. Provide pharmacy records and provider documentation of previous trials and outcomes.

What happens if my employer plan is self-funded? Self-funded ERISA plans may not be subject to Washington state external review laws. Contact the U.S. Department of Labor for ERISA plan appeals guidance, though many employers voluntarily use IRO processes.

How much does external review cost in Washington? External review through the Office of the Insurance Commissioner is free for consumers. The IRO process is funded through insurer fees, not patient costs.

Can I continue current medication during appeals? Washington law allows continued coverage during appeals in some circumstances. Contact the Office of the Insurance Commissioner at (800) 562-6900 for guidance on your specific situation.

Sources & Further Reading

This guide is for informational purposes only and does not constitute medical or legal advice. Coverage decisions depend on individual plan terms and medical circumstances. For personalized assistance with appeals and prior authorization challenges, consider consulting with specialists like Counterforce Health, who help transform insurance denials into successful approvals through evidence-based appeal strategies. Always verify current policies and procedures with your insurer and healthcare providers.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.